Dapivirine + Copper + Zinc IVR MPT
- User: Female
- Hormonal: Non-Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Short-Acting
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): Queen's University Belfast
Details
- API: Dapivirine, Copper, Zinc
-
Mechanism of Action:
- Anti-Microbial
- Inhibition of Sperm Motility
- Inhibition of Sperm Capacitation
- Inactive Materials: Silicone
- Regimen: Not Yet Determined
- MPT: Potential MPT
- Promising Attributes: The method would be user controlled and non-hormonal, both characteristics aligned with user interest, and would provide protection against both pregnancy and HIV.
Product Status
Active/Recent Early Development
History
2025: Queen's University Belfast publishes results of release profile analysis of IVRs integrating Dapivirine, copper, and zinc, concluding that these materials can be effectively integrated into a ring format and are compatible with one another.